Alzheimer's Disease Analysis

Alzheimer's Disease Analysis

Alzheimer's disease is a degenerative, neurological disease that affects millions of people every year. It is a specific type of dementia that affects both memory and cognitive functions. The cause of the disease has been well studied along with many types of ion interactions that either lessen or worsen symptoms. Currently there is no treatment for this disease, but many researchers are working to find a cure.

Alzheimer's disease is categorized by slight impaired memory to severe cognitive loss (Mayeux, 2010). This can be seen by a loss in retaining new memories as well as a decrease in language, reasoning and decision making (Mayeux, 2010). This disease is progressive and patients only get worse with time and it finally ends in death with both mental and functional disabilities (Mayeux, 2010). This is seen mainly in people 65 and older and studies have shown that age and aging is the highest risk factor for the developing the disease (Lundkvist, 2014).

The disease was discovered by a German neuropsychiatrist by the name of Alois Alzheimer. One of his patients died after having ... Show more content on Helpwriting.net ...Mohs, R. (2013). A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease. New England Journal of Medicine, 369(4), 341–350.

Doody, R., Thomas, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., ... Mohs, R. (2014). Phase 3 Trials of Solanezumab for Mild–to–Moderate Alzheimer's Disease. New England Journal of Medicine, 370(4), 311–321.

Lambracht–Washington, D., & Rosenberg, R. (2013). Anti–amyloid–beta to tau–based immunization: Developments in immunotherapy for Alzheimer's disease. ImmunoTargets and Therapy, 2013(2), 105–114.

Lundkvist, J., Halldin, M., Sandin, J., Nordvall, G., Forsell, P., Svensson, S., ... Ekstrand, J. (2014). The battle of Alzheimer's disease – the beginning of the future Unleashing the potential of academic discoveries. Frontiers in Pharmacology,

... Get more on HelpWriting.net ...